<--- Back to Details
First PageDocument Content
Neuroendocrinology / Endocrine system / Pituitary adenoma / Growth hormones / Acromegaly / Adrenal gland disorders / Prolactinoma / Multiple endocrine neoplasia / Hypopituitarism / Medicine / Endocrinology / Anatomy
Date: 2013-06-28 10:49:53
Neuroendocrinology
Endocrine system
Pituitary adenoma
Growth hormones
Acromegaly
Adrenal gland disorders
Prolactinoma
Multiple endocrine neoplasia
Hypopituitarism
Medicine
Endocrinology
Anatomy

Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study Adrian F. Daly, Maria A. Tichomirowa, Patrick Petrossians, Elina He

Add to Reading List

Source URL: orbi.ulg.ac.be

Download Document from Source Website

File Size: 1,23 MB

Share Document on Facebook

Similar Documents

It should not be used by women who become pregnant during cabergoline cost without insurance treatment. The recommended doses of zolpidem may be increased if dosing instructions are not the same entity. Infrequent: cysti

It should not be used by women who become pregnant during cabergoline cost without insurance treatment. The recommended doses of zolpidem may be increased if dosing instructions are not the same entity. Infrequent: cysti

DocID: 1phXe - View Document

liquid cabergoline serge kreutz cabergoline dosing, cabergoline help, cabergoline dostinex cabergoline for pituitary adenoma. bromocriptine or cabergoline, libido cabergoline. cabergoline dosage cabergoline veterinary ho

liquid cabergoline serge kreutz cabergoline dosing, cabergoline help, cabergoline dostinex cabergoline for pituitary adenoma. bromocriptine or cabergoline, libido cabergoline. cabergoline dosage cabergoline veterinary ho

DocID: 1fQef - View Document

ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI:  Published online: February 15, 2012

ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI: Published online: February 15, 2012

DocID: 1avf1 - View Document

Interim Clinical Commissioning Policy Statement: Stereotactic Radiosurgery / Radiotherapy for Ocular Melanoma and Pituitary Adenoma September 2013

Interim Clinical Commissioning Policy Statement: Stereotactic Radiosurgery / Radiotherapy for Ocular Melanoma and Pituitary Adenoma September 2013

DocID: 18SXi - View Document

doi:j.jfms

doi:j.jfms

DocID: 18ujE - View Document